1 CHMP udtrykte endvidere betænkelighed ved omfanget af anvendelsen af Protopy hos børn under to år (ikke godkendt), hos hvem immunsystemet stadig er under udvikling.
1 The CHMP also expressed concerns about the degree of use of Protopy in children under the age of 2 (not approved) when the immune system is still developing.